Topics

Articles

With new cellular and genetic therapies, the reimbursement process will need to evolve

Connecting with buying influences in integrated delivery networks is a challenge

14th edition attracted 59 commercial plans as respondents, representing 100 million lives

Company celebrates its growth at annual industry event

Specialty-pharma support providers have a potential benefit in behavioral targeting insights

Company offers a risk-mitigation analytics suite to enable pharma monitoring

While nominal spending was up 1.4%, actual net spending was only 0.6% greater than 2016

Vaccines for adult disease states and for tropical diseases expand the market beyond traditional pediatric applications